AADAC
Basic information
Region (hg38): 3:151814073-151828488
Links
Phenotypes
GenCC
Source:
- Tourette syndrome (No Known Disease Relationship), mode of inheritance: Unknown
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the AADAC gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 28 | 29 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 28 | 2 | 0 |
Variants in AADAC
This is a list of pathogenic ClinVar variants found in the AADAC region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-151814177-G-A | Likely benign (Jan 01, 2023) | |||
3-151814206-T-C | not specified | Uncertain significance (Jun 22, 2021) | ||
3-151814209-C-T | not specified | Uncertain significance (Feb 26, 2025) | ||
3-151814224-C-T | not specified | Uncertain significance (Jan 22, 2024) | ||
3-151814236-A-T | not specified | Uncertain significance (Oct 27, 2021) | ||
3-151814241-G-A | not specified | Likely benign (Mar 15, 2024) | ||
3-151814277-C-T | not specified | Uncertain significance (Aug 30, 2021) | ||
3-151814294-A-C | not specified | Uncertain significance (Dec 13, 2022) | ||
3-151817418-T-A | not specified | Uncertain significance (Aug 04, 2023) | ||
3-151817418-T-C | not specified | Uncertain significance (Aug 01, 2024) | ||
3-151817438-G-A | not specified | Uncertain significance (Nov 02, 2023) | ||
3-151817456-G-A | not specified | Uncertain significance (Apr 07, 2023) | ||
3-151817517-A-G | not specified | Uncertain significance (Jul 06, 2021) | ||
3-151820383-C-G | not specified | Uncertain significance (Feb 07, 2023) | ||
3-151824728-G-T | not specified | Uncertain significance (Feb 07, 2025) | ||
3-151824736-C-T | not specified | Uncertain significance (Jan 29, 2025) | ||
3-151824737-G-A | not specified | Uncertain significance (Feb 19, 2025) | ||
3-151824787-T-G | not specified | Uncertain significance (Oct 25, 2022) | ||
3-151827592-A-T | not specified | Uncertain significance (Mar 17, 2023) | ||
3-151827593-T-A | not specified | Uncertain significance (Dec 05, 2022) | ||
3-151827659-A-C | not specified | Uncertain significance (Dec 21, 2023) | ||
3-151827681-A-T | not specified | Uncertain significance (May 15, 2023) | ||
3-151827687-C-A | not specified | Uncertain significance (Sep 09, 2024) | ||
3-151827783-C-G | not specified | Uncertain significance (Dec 14, 2024) | ||
3-151827928-C-A | not specified | Uncertain significance (Mar 01, 2025) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
AADAC | protein_coding | protein_coding | ENST00000232892 | 5 | 14452 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00291 | 0.947 | 125676 | 0 | 48 | 125724 | 0.000191 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.364 | 195 | 210 | 0.929 | 0.0000106 | 2587 |
Missense in Polyphen | 58 | 67.316 | 0.86161 | 871 | ||
Synonymous | -0.599 | 87 | 80.2 | 1.09 | 0.00000429 | 777 |
Loss of Function | 1.71 | 6 | 12.5 | 0.478 | 5.24e-7 | 181 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000120 | 0.000120 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00174 | 0.00174 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.0000533 | 0.0000528 |
Middle Eastern | 0.00174 | 0.00174 |
South Asian | 0.000232 | 0.000229 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Displays cellular triglyceride lipase activity in liver, increases the levels of intracellular fatty acids derived from the hydrolysis of newly formed triglyceride stores and plays a role in very low-density lipoprotein assembly. Displays serine esterase activity in liver. Deacetylates a variety of arylacetamide substrates, including xenobiotic compounds and procarcinogens, converting them to the primary arylamide compounds and increasing their toxicity. {ECO:0000269|PubMed:17936933, ECO:0000269|PubMed:19339378, ECO:0000269|PubMed:22207054, ECO:0000269|PubMed:22415931, ECO:0000269|PubMed:23542347}.;
- Pathway
- Phase I - Functionalization of compounds;Biological oxidations;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.0773
Intolerance Scores
- loftool
- 0.819
- rvis_EVS
- -0.09
- rvis_percentile_EVS
- 46.92
Haploinsufficiency Scores
- pHI
- 0.0240
- hipred
- N
- hipred_score
- 0.146
- ghis
- 0.459
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.673
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Aadac
- Phenotype
Gene ontology
- Biological process
- xenobiotic metabolic process;positive regulation of triglyceride catabolic process
- Cellular component
- endoplasmic reticulum membrane;integral component of membrane;organelle membrane
- Molecular function
- catalytic activity;triglyceride lipase activity;lipase activity;serine hydrolase activity;deacetylase activity